P
Pepex Biomedical
Pepex Biomedical | Enzymatic Biosensors | Blood Glucose Meter
About Pepex Biomedical
Pepex Biomedical specializes in developing advanced electrochemical biosensor technology aimed at revolutionizing diabetes management and clinical care. The company offers a diagnostic blood glucose measuring system that is wirelessly enabled to connect to the cloud, providing immediate diagnostic results and significantly improving the accuracy of glucose testing. Pepex's technology is designed to help physicians make precise, personalized care decisions at the right time, thereby improving patient compliance and outcomes. The company primarily serves healthcare providers, payers, and patients, operating in the medical device and healthcare technology market. Pepex's business model involves the commercialization of its proprietary biosensor technology through the sale of medical devices and related services. Revenue is generated from device sales, cloud-based data services, and potentially from partnerships with healthcare organizations.
Source: Dealroom company dataAt a glance
- Founded
- 2001
- Headquarters
- Tucson, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- RLReCap Holdings, LLC
Series A1 investor entered at this stage
- JLJIANGSU TEAMWORK TRADING CO., LTD
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pepex Biomedical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pepex Biomedical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.